SenesTech Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

PHOENIX, April 12, 2023 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”) (www.senestech.com), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the closing of its…